Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis
Osteoarthritis (OA) is a heterogeneous disease with varying degrees of inflammatory responses, structural changes, functional insufficiency, and disease progression as a whole. Some OA phenotypes are characterized by a high local inflammatory response, persistent pain, persistent synovitis, and seve...
Main Authors: | S. G. Anikin, L. I. Alekseeva, A. M. Lila |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-05-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/916 |
Similar Items
-
Hand osteoarthritis: diagnosis, pathogenesis, treatment
by: R. M. Balabanova, et al.
Published: (2018-04-01) -
A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
by: R. M. Balabanova
Published: (2018-12-01) -
Effect of colchicine, methotrexate, and hydroxychloroquine therapy on cardiovascular outcomes in patients with calcium pyrophosphate crystal deposition disease
by: M. S. Eliseev, et al.
Published: (2021-12-01) -
Early osteoarthritis: development of diagnostic criteria
by: L. I. Alekseeva, et al.
Published: (2020-09-01) -
Experience with methotrexate in a patient with calcium pyrophosphate crystal deposition disease
by: E. V. Ilyinykh, et al.
Published: (2019-10-01)